Global  

Oklahoma judge to rule on J&J opioid case

Video Credit: Reuters Studio - Duration: 01:46s - Published
Oklahoma judge to rule on J&J opioid case

Oklahoma judge to rule on J&J opioid case

An Oklahoma judge will rule on Monday on whether Johnson & Johnson should be held liable in a lawsuit by the state's attorney general who argues the drugmaker should be forced to pay $17 billion for fueling the opioid epidemic.

Jillian Kitchener has more.

0
shares
ShareTweetSavePostSend
 

A historic trial is set to come to an end, Monday, when an Oklahoma judge rules on whether pharmaceutical giant Johnson & Johnson should be held liable for fueling an opioid epidemic.

Oklahoma’s Attorney General argues Johnson & Johnson should be forced to pay 17 billion dollars, for marketing their prescription painkillers as safe and effective while downplaying their addictive and deadly potential.

State attorney Brad Beckworth claims thousands of Oklahomans have died from opioid overdoses since the year 2000.

(SOUNDBITE) (English) LAWYER FOR OKLAHOMA, BRAD BECKWORTH, SAYING: “This company cut and ran, took the money and ran and they left us here holding the body bags.” The company denies wrongdoing.

It says its painkillers were a tiny fraction of all opioids prescribed in the state… and that its marketing claims had scientific support.

Defense attorney Larry Ottaway, in closing arguments, said the drugs were made to HELP patients function.

(SOUNDBITE) (English) DEFENSE ATTORNEY FOR J&J, LARRY OTTAWAY, SAYING: “They’re innovative, they work, and they have advantages no other opioids have because this company took their responsibility to those patients seriously.” OxyContin maker Purdue Pharma and Teva Pharmaceutical were originally also defendants in the case.

BUT - Purdue Pharma settled with Oklahoma for $270 million and Teva for $85 million.

This Oklahoma opioids case is the first to go to trial in the United States.

The outcome is being closely watched by plaintiffs in hundreds of other opioid lawsuits.




💡 One News Page Knowledge: Other News Mentions

Oklahoma Oklahoma State in the United States

Even if oil and gas disappear, pipelines are here to stay

A warning sign for Petroleum Pipeline is pictured on May 4th, 2020, in Cushing, Oklahoma. | Photo by Johannes Eisele / AFP via Getty Images

People..

The Verge

To What Extent Are Political And Religious Leaders Liable For Their Followers COVID-19 Related Deaths?

Article by WN.Com Correspondent Dallas Darling Critics of President Donald Trump are calling the death of Herman Cain “murder” or “suicide.” The former..
WorldNews
U.S. teachers protest school reopenings [Video]

U.S. teachers protest school reopenings

[NFA] Teachers from dozens of school districts nationwide protested plans by some governors to resume in-class instruction, saying it threatens the safety of students, their families and educators. Lisa Bernhard produced this report.

Credit: Reuters - Politics    Duration: 01:45Published

'Lucky recipient of a monster': Man snags 146-pound world record paddlefish in Oklahoma

The Oklahoma paddlefish weighed 146 pounds 11 ounces, and estimated to be 25 to 35 years old. After photos, the fish was released back into the water.

USATODAY.com
Besides Lacking Beds, Eleven US States Face Critical Shortage Of ICU Medical Professionals [Video]

Besides Lacking Beds, Eleven US States Face Critical Shortage Of ICU Medical Professionals

As COVID-19 infections surge, health care professionals across the US are struggling to keep up with the demand for personal protective equipment. But according to UPI, a new report reveals that in 11 states, there's a shortage of intensive care unit doctors to take care of non-COVID-19 patients, too. This week's update shows that Alabama, Arkansas, Florida, Idaho, Louisiana, Mississippi, Nevada, Oklahoma, South Carolina, Utah and Washington all could face a shortage of intensivists.

Credit: Wochit News    Duration: 00:34Published

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

J&J: Consumers Have Given Up On Skincare [Video]

J&J: Consumers Have Given Up On Skincare

On Thursday, Johnson & Johnson detailed it's quarterly earnings. The company said shoppers are not buying skincare and beauty products as more and more people remain isolated at home. Business Insider said the negative hit on skincare has cost the company 3.4% in terms of worldwide sales.

Credit: Wochit News    Duration: 00:30Published
Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published

You Might Like

Related news from verified sources

Oklahoma judge expected to rule Monday in opioid case

NORMAN, Okla. (AP) — A judge is expected to rule next week in Oklahoma’s case alleging consumer...
Seattle Times - Published Also reported by •NPRReutersWorldNews


$572M ruling in Oklahoma opioid lawsuit could spell trouble for Triangle pharmas

A judge's ruling in Oklahoma could mean bad news for opioid companies across the country –...
bizjournals - Published

Johnson & Johnson ordered to pay $572 million in Oklahoma

Oklahoma [USA], Aug 27 (ANI): Medical giant Johnson and Johnson has been ordered to pay USD 572...
Sify - Published Also reported by •CNACBS News



Tweets about this


Related videos from verified sources

Despite J&J's Ruling, Is the Healthcare  Sector Still a Good Investing Opportunity? [Video]

Despite J&J's Ruling, Is the Healthcare Sector Still a Good Investing Opportunity?

So, how should investors approach healthcare after a headline like a judge in Oklahoma ruling against Johnson & Johnson in an opioid case? J&J was ordered to pay $572 million to the state of Oklahoma...

Credit: The Street     Duration: 01:28Published
J&J "up to their necks" in the opioids crisis: Oklahoma AG [Video]

J&J "up to their necks" in the opioids crisis: Oklahoma AG

Mike Hunter, the state attorney general for Oklahoma, says the evidence is clear that Johnson and Johnson is "up to their necks" in the opioid crisis. A state judge ruled yesterday,..

Credit: Rumble     Duration: 01:03Published
Oklahoma Finds J&J Liable In Opioid Epidemic [Video]

Oklahoma Finds J&J Liable In Opioid Epidemic

An Oklahoma judge has found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers and ordered the drugmaker to pay damages of $572 million.

Credit: HuffPost UK STUDIO     Duration: 01:21Published